Analysis of Chronic Disease Direct Cost at Public Primary Health Cares in Indonesia

Authors

  • Indriyati Hadi Sulistyaningrum Doctoral Student, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia and Pharmacy Department, Medical Faculty, Islam Sultan Agung University, Semarang, Indonesia
  • Susi Ari Kristina Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia
  • Ali Ghufron Mukti Faculty of Medicine, Nursing, and Public Health, Gadjah Mada University, Yogyakarta, Indonesia
  • - Satibi Department of Pharmaceutics, Faculty of Pharmacy, Gadjah Mada University, Yogyakarta, Indonesia

DOI:

https://doi.org/10.3329/bjms.v20i4.54131

Keywords:

Universal Health Coverage; Chronic Disease; Drug Cost; Capitation; Indonesia

Abstract

Objectives: This study aims to analyze the of drug costs for patients with chronic diseases in the capitation system in public primary health cares (Public PHCs).

Materials and Methods: This research is a quantitative study with an observational cross-sectional approach at 16 Public PHCs. Data collection used the retrospective method. The total sample was 293 outpatients in 2016.

Results: The results showed that 63% of patients are female. The most patients are aged between 56-65 years (37%). The average drug cost for patients receiving more than 3 types of drugs is IDR 7,726. The biggest drug cost is patients with DM type 2 with which the average cost is IDR 7.400. And the metformin treatment is 17 (6%) patients with the cost IDR 4,500,-. Chi-square analysis shows that the quantity of drug items, type of disease and prescriptions there are have significant effect on drug cost (p-value <0.05). However, gender and age group there are no significant effect on drug cost (p-value >0.05). Drug prescriptions are an important component in managing chronic diseases patients. Prescribing costs provide important information in the sustainability of the management of chronic disease programs.

Conclusion: This study recommends that the prolanis policy in public PHCs is focused on the elderly age group patients and female group.

Bangladesh Journal of Medical Science Vol.20(4) 2021 p.762-767

Downloads

Download data is not yet available.
Abstract
9
PDF
12

Downloads

Published

2021-06-18

How to Cite

Sulistyaningrum, I. H., Kristina, S. A., Mukti, A. G., & Satibi, .-. (2021). Analysis of Chronic Disease Direct Cost at Public Primary Health Cares in Indonesia. Bangladesh Journal of Medical Science, 20(4), 762–767. https://doi.org/10.3329/bjms.v20i4.54131

Issue

Vol. 20 No. 4 (2021)

Section

Original Articles

License

Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:

  1. Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.

  2. Creative Commons Licence
    Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.
  3. Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
  4. Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.